[HTML][HTML] Nanostructured lipid carriers for delivery of chemotherapeutics: A review

M Haider, SM Abdin, L Kamal, G Orive - Pharmaceutics, 2020 - mdpi.com
The efficacy of current standard chemotherapy is suboptimal due to the poor solubility and
short half-lives of chemotherapeutic agents, as well as their high toxicity and lack of …

[HTML][HTML] Polysaccharide-based nanomedicines for cancer immunotherapy: A review

Y Zeng, Y Xiang, R Sheng, H Tomás, J Rodrigues… - Bioactive Materials, 2021 - Elsevier
Cancer immunotherapy is an effective antitumor approach through activating immune
systems to eradicate tumors by immunotherapeutics. However, direct administration of …

Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy

C Liu, X Yan, Y Zhang, M Yang, Y Ma, Y Zhang… - Journal of …, 2022 - Springer
Background Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by
diffuse inflammation of the colonic mucosa and a relapsing and remitting course. The current …

Flavonoids in inflammatory bowel disease: a review

T Vezza, A Rodríguez-Nogales, F Algieri, MP Utrilla… - Nutrients, 2016 - mdpi.com
Inflammatory bowel disease (IBD) is characterized by chronic inflammation of the intestine
that compromises the patients' life quality and requires sustained pharmacological and …

[HTML][HTML] Role of dietary polyphenols in the management of peptic ulcer

MH Farzaei, M Abdollahi, R Rahimi - World journal of …, 2015 - ncbi.nlm.nih.gov
Peptic ulcer disease is a multifactorial and complex disease involving gastric and duodenal
ulcers. Despite medical advances, the management of peptic ulcer and its complications …

Curcumin and its modified formulations on inflammatory bowel disease (IBD): The story so far and future outlook

A Karthikeyan, KN Young, M Moniruzzaman… - Pharmaceutics, 2021 - mdpi.com
Inflammatory bowel disease (IBD) is a chronic relapsing and remitting inflammatory disorder
of the small intestine and colon. IBD includes ulcerative colitis (UC) and Crohn's disease …

Colon-targeted oral nanoparticles based on ROS-scavenging hydroxyethyl starch-curcumin conjugates for efficient inflammatory bowel disease therapy

C Xu, S Chen, C Chen, Y Ming, J Du, J Mu… - International Journal of …, 2022 - Elsevier
Co-delivery of anti-inflammatory drugs and reactive oxygen species (ROS) scavengers by
stimuli-responsive oral nanoparticles is deemed to be a favorable strategy for inflammatory …

Single components of botanicals and nature-identical compounds as a non-antibiotic strategy to ameliorate health status and improve performance in poultry and pigs

B Rossi, A Toschi, A Piva, E Grilli - Nutrition Research Reviews, 2020 - cambridge.org
In the current post-antibiotic era, botanicals represent one of the most employed nutritional
strategies to sustain antibiotic-free and no-antibiotic-ever production. Botanicals can be …

Targeting NF-κB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines

PD Lu, YH Zhao - Chinese medicine, 2020 - Springer
Nuclear factor-kappa B (NF-κB) is a kind of multi-functional nuclear transcription factor
involved in regulating gene transcription to influence pathological evolution of inflammatory …

Immunomodulatory effects of curcumin in systemic autoimmune diseases

S Chamani, M Moossavi, A Naghizadeh… - Phytotherapy …, 2022 - Wiley Online Library
Systemic autoimmune diseases like rheumatoid arthritis, multiple sclerosis, and systemic
lupus erythematosus represent various autoimmune conditions identified by immune system …